Salem Capital Management’s GSK GSK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q4 | – | Sell |
-4,680
| Closed | -$252K | – | 66 |
|
2016
Q3 | $252K | Hold |
4,680
| – | – | 0.14% | 60 |
|
2016
Q2 | $254K | Sell |
4,680
-79,988
| -94% | -$4.34M | 0.15% | 60 |
|
2016
Q1 | $4.29M | Sell |
84,668
-3,288
| -4% | -$167K | 2.41% | 18 |
|
2015
Q4 | $4.44M | Buy |
87,956
+676
| +0.8% | +$34.1K | 2.51% | 17 |
|
2015
Q3 | $4.2M | Sell |
87,280
-1,496
| -2% | -$71.9K | 2.46% | 18 |
|
2015
Q2 | $4.62M | Sell |
88,776
-1,960
| -2% | -$102K | 2.4% | 20 |
|
2015
Q1 | $5.23M | Sell |
90,736
-1,280
| -1% | -$73.8K | 2.66% | 18 |
|
2014
Q4 | $4.92M | Sell |
92,016
-4,400
| -5% | -$235K | 2.34% | 20 |
|
2014
Q3 | $5.54M | Buy |
96,416
+4,912
| +5% | +$282K | 2.58% | 19 |
|
2014
Q2 | $6.12M | Sell |
91,504
-3,036
| -3% | -$203K | 2.71% | 17 |
|
2014
Q1 | $6.31M | Sell |
94,540
-2,320
| -2% | -$155K | 2.77% | 16 |
|
2013
Q4 | $6.46M | Buy |
96,860
+160
| +0.2% | +$10.7K | 2.79% | 13 |
|
2013
Q3 | $6.06M | Sell |
96,700
-1,320
| -1% | -$82.8K | 2.79% | 13 |
|
2013
Q2 | $6.12M | Buy |
+98,020
| New | +$6.12M | 2.92% | 9 |
|